Tags

Type your tag names separated by a space and hit enter

IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?
JAMA. 2021 08 10; 326(6):483-485.JAMA

Authors+Show Affiliations

Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco.Departments of Medicine and Division of Infectious Diseases, HIV and Global Medicine, Zuckerberg San Francisco General Hospital, and the University of California, San Francisco.

Pub Type(s)

Editorial
Comment

Language

eng

PubMed ID

34228779

Citation

Matthay, Michael A., and Anne F. Luetkemeyer. "IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?" JAMA, vol. 326, no. 6, 2021, pp. 483-485.
Matthay MA, Luetkemeyer AF. IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How? JAMA. 2021;326(6):483-485.
Matthay, M. A., & Luetkemeyer, A. F. (2021). IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How? JAMA, 326(6), 483-485. https://doi.org/10.1001/jama.2021.11121
Matthay MA, Luetkemeyer AF. IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How. JAMA. 2021 08 10;326(6):483-485. PubMed PMID: 34228779.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How? AU - Matthay,Michael A, AU - Luetkemeyer,Anne F, PY - 2021/7/7/pubmed PY - 2021/8/13/medline PY - 2021/7/6/entrez SP - 483 EP - 485 JF - JAMA JO - JAMA VL - 326 IS - 6 SN - 1538-3598 UR - https://www.unboundmedicine.com/medline/citation/34228779/IL-6_Receptor_Antagonist_Therapy_for_Patients_Hospitalized_for_COVID-19:_Who,_When,_and_How L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.11121 DB - PRIME DP - Unbound Medicine ER -